Follow
Ali Ünal
Ali Ünal
Erciyes University Medical School Department Hematology
Verified email at erciyes.edu.tr - Homepage
Title
Cited by
Cited by
Year
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …
M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...
The Lancet 394 (10214), 2096-2107, 2019
610*2019
A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer
M Altinbas, HS Coskun, O Er, M Ozkan, B Eser, A Unal, M Cetin, S Soyuer
Journal of thrombosis and haemostasis 2 (8), 1266-1271, 2004
6032004
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 …
MA Dimopoulos, E Terpos, M Boccadoro, S Delimpasi, M Beksac, ...
The Lancet Oncology 22 (6), 801-812, 2021
2432021
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
2412019
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
A Bacigalupo, G Socié, RM Hamladji, M Aljurf, A Maschan, ...
haematologica 100 (5), 696, 2015
1792015
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body …
A Nagler, V Rocha, M Labopin, A Unal, T Ben Othman, A Campos, L Volin, ...
Journal of clinical oncology 31 (28), 3549-3556, 2013
1722013
The role of plasma exchange in HELLP syndrome
B Eser, M Guven, A Unal, R Coskun, F Altuntas, M Sungur, IS Serin, I Sari, ...
Clinical and applied thrombosis/hemostasis 11 (2), 211-217, 2005
1212005
A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the …
I Sari, F Altuntas, S Hacioglu, I Kocyigit, A Sevinc, S Sacar, K Deniz, E Alp, ...
American journal of hematology 83 (4), 334-339, 2008
962008
Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study
L Kaynar, F Altuntas, I Aydogdu, B Turgut, I Kocyigit, SK Hacıoglu, ...
Transfusion and Apheresis Science 38 (2), 109-115, 2008
922008
Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma
S Saarinen, M Aavikko, K Aittomäki, V Launonen, R Lehtonen, K Franssila, ...
Blood, The Journal of the American Society of Hematology 118 (3), 493-498, 2011
842011
Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study
M Mohty, E Terpos, MV Mateos, M Cavo, S Lejniece, M Beksac, ...
Clinical Lymphoma Myeloma and Leukemia 18 (10), e401-e419, 2018
752018
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
M Beksac, GC Seval, N Kanellias, D Coriu, L Rosiñol, G Ozet, ...
Haematologica 105 (1), 201, 2020
712020
Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study
F Altuntas, I Aydogdu, S Kabukcu, I Kocyigit, K Cıkım, I Sarı, MA Erkut, ...
Transfusion and Apheresis Science 36 (1), 57-67, 2007
702007
Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes
A Abaci, Y Yilmaz, M Caliskan, F Bayram, M Cetin, A Unal, S Cetin
Thrombosis research 116 (6), 465-470, 2005
682005
Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis
E Kaya, M Keklik, M Şencan, M Yilmaz, A Keskin, I Kiki, MA Erkurt, ...
Transfusion and Apheresis Science 48 (3), 349-352, 2013
612013
No improvement of survival with reduced-versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
U Thiel, A Wawer, P Wolf, M Badoglio, A Santucci, T Klingebiel, O Basu, ...
Annals of oncology 22 (7), 1614-1621, 2011
582011
Overexpression of cyclooxygenase‐2 in multiple myeloma: association with reduced survival
M Cetin, S Buyukberber, M Demir, I Sari, I Sari, K Deniz, B Eser, F Altuntas, ...
American journal of hematology 80 (3), 169-173, 2005
582005
Pesg PNH diagnosis, follow-up and treatment guidelines
F Sahin, OM Akay, M Ayer, MS Dal, S Ertop, O Ilhan, V Karakus, ...
American Journal of Blood Research 6 (2), 19, 2016
522016
Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma
M Çetin, D Demirci, A Ünal, M Altinbaş, M Güven, K Ünlühizarci
Human & experimental toxicology 18 (3), 137-140, 1999
501999
The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload
S Sivgin, S Baldane, G Akyol, M Keklik, L Kaynar, F Kurnaz, C Pala, ...
Transfusion and Apheresis Science 49 (2), 295-301, 2013
462013
The system can't perform the operation now. Try again later.
Articles 1–20